Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK

INTRODUCTION: In patients with inflammatory bowel disease (IBD), iron deficiency anaemia (IDA) can impair quality of life and increase healthcare costs. Treatment options for IDA-associated IBD include oral iron and intravenous iron formulations (such as ferric carboxymaltose [FCM], ferric derisomal...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clinicoecon Outcomes Res
Hoofdauteurs: Aksan, Aysegül, Beales, Ian L P, Baxter, Garth, de Arellano, Antonio Ramirez, Gavata, Simona, Valentine, William J, Hunt, Barnaby
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove 2021
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216635/
https://ncbi.nlm.nih.gov/pubmed/34168471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S306823
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items